Jiachuan Yu1, Yuanyuan Luo2, Huidan Jin1, Jiaxin Lv1, Tingting Zhou1, Iddrisu Baba Yabasin1, Qingping Wen1. 1. Department of Anesthesiology, The First Affiliated Hospital of Dalian Medical University, Dalian, China. 2. CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China; University of Chinese Academy of Sciences, Beijing, China.
Abstract
Entities:
Keywords:
analgesic effect; bone cancer pain; bone destruction; glia activation; scorpion
A significant proportion of cancerpatients with bone metastases usually suffer
from severe pain and have a low quality of life.[1-3] Bone complications
caused by metastasis are found in 70% of patients with advanced prostate or
breast cancer,[4,5] and metastasis is considered as the dominant
contributor to malignancy-induced bone pain. Moreover, this chronic pain
condition can have an unpredictable onset and increase in severity with
progression of malignancy. Despite the availability of bisphosphonates,
nonsteroidal anti-inflammatory drugs and opioids, many patients with bone
cancer pain (BCP) report limited pain relief and adverse side effects, such
as neuropsychiatric symptoms and gastric bleeding.[6-8] No new
pharmacotherapy has emerged, and there is an urgent need for new BCP
treatments.In China, the scorpion Buthus martensii Karsch (BmK) has been an essential
material in Chinese traditional medicine for thousands of years. Whole
scorpions, scorpion tails, and their extracts have been found to be
effective in treating certain neural diseases such as apoplexy, epilepsy,
facial paralysis, and hemiplegia, in addition to their use for soothing the
nerves and relieving pain caused by meningitis, cerebral palsy, and
rheumatism.[9,10] Recent study
demonstrated that the analgesic effect of scorpion was probably accomplished
through opioid receptors on lateral septal nucleus in central nervous system.[11] Others found that peripheral and spinal mitogen-activated protein
kinases and the voltage-gated calcium channels in dorsal root ganglia
neurons may be potential mechanisms of the antinociception provided by
scorpion.[12-14] However, research
on the effects or mechanisms of scorpion in BCP is limited.Previous studies have exposed the critical importance of glial cells to a
variety of biological functions, including pain perception and
modulation.[15,16] Astrocytes and
microglia in the spinal cord participate in the initiation and maintenance
of persistent pain induced by tissue inflammation and nerve
injury.[17-19] During pathological pain status, activated astrocytes
and microglia release various inflammatory cytokines, such as interleukin
(IL)-1β and tumor necrosis factor-alpha (TNF-α).[20,21] The production of
proinflammatory mediators modulates pain sensitivity, which leads to the
development of peripheral and central sensitization, and induction of
chronic pain conditions.[22] However, the effects of scorpion on the spinal cord astrocytes and
microglia in BCP have not been investigated.In this study, we demonstrated the analgesic effect of scorpion in a malignant
bone painmouse model and examined the underlying mechanism. Our findings
suggested that scorpion may be a choice for BCP treatment.
Materials and methods
Cell culture
Walker 256 mammary gland carcinoma cell line was a gift from Prof.
Changsheng Dong (Shanghai Research Institute of Traditional Chinese
Medicine, China). Walker 256 cells were cultured in RPMI 1640 medium
(GIBCO; MD, USA) containing 10% fetal bovine serum (heat-inactivated)
(Hyclone; UT, USA), 1% L-glutamine and 2% penicillin/streptomycin
(GIBCO; MD, USA). Cells were detached from the flask by 0.25% trypsin
for subsequent preparation of injection. Briefly, the cells were
collected by centrifugation and the pellet was resuspended in
phosphate-buffered saline (PBS).
Experimental animals
Female Sprague-Dawley (SD) rats were from Institute of Genome engineered
Animal Models for Human Diseases (Dalian, China). All animals were
housed with ad libitum access to water and food in a 12/12-h
light–dark cycle regime and environmental temperature was controlled
at 22 ± 1°C. Animals were housed for seven days to acclimatize before
the experimental procedures. All animals were housed and handled in
accordance with the Animal Care and Use Committee at Dalian Medical
University.
Surgical procedure for establishing a rat model of BCP
A rat model of BCP was established following previous report.[23] For cell preparation, ascitic cancer cells 0.5 ml
(2 × 107 cells/ml) were injected into the abdominal
cavity of 60–80 g female SD juvenile rats. After six to seven days,
ascitic fluid was extracted from above rats. Then, cells were
collected by centrifugation of 2 ml ascitic fluid for 3 min at
1200 r/min. The pellet was washed with 10 ml PBS and recentrifuged for
3 min at 1200 r/min. Before the final pellet was resuspended in an
appropriate volume to achieve final concentrations for injection, the
pellet was suspended in 10 ml PBS and cells were counted using a
hemocytometer (2 × 107 cells/ml). The cell suspension was
kept on ice until injected into 180–220 g female SD adult rats. For
the sham group, PBS was prepared in the same volume for injection. For
surgery, female SD adult rats were deeply anesthetized with sodium
pentobarbital (50 mg/kg, intraperitoneal injection). Bilateral
superficial incisions were made in the skin overlying the patella
after disinfected with 70% v/v ethanol. Then, more incisions were cut
along the patellar ligament in order to expose the tibia head with
minimal damage. A 23-gauge needle was inserted at the site of
intercondylar eminence and pierced 7 mm below the knee joint into the
medullary cavity of tibia. The needle was then removed and replaced
with a 29-gauge needle (long thin blunt needle) attached to a 10 μl
microinjection syringe. Then, carcinoma cells (2 × 105) in
10 μl PBS or PBS (sham group) 10 μl were slowly injected into the left
tibia cavity. The syringe was left in place for an additional 2 min to
prevent the carcinoma cells from leaking out along the injection
track. The injection site was closed using bone wax while the syringe
was removed. The wound was closed and dusted with penicillin powder
after the injection site was closed using gelatin sponge.
Drug administration
Intragastric administration of scorpion was used for the treatment of BCPrats. Briefly, rats (n = 40) were randomly divided into four groups:
sham group, BCP group, BCP+scorpion (prophylactic) group and
BCP+scorpion (reversal), each group contained 10 rats. The scorpion
was decocted twice with distilled water for 1 h. The decoction was
collected, filtered, merged, and concentrated to 1 g/mL (equivalent to
crude herb materials) and stored at −20°C. Scorpion-contained
decoction was given to the rats at 108 mg/200 g/d from 4 to 21 days
(prophylactic) or 14 to 21 days (reversal) after modeling, and rats in
sham group and BCP group were given same volume of saline every
day.
Mechanical allodynia test
Rats were placed on a 5 × 5 mm wire mesh grid floor and allowed to
habituate for 30 min. Test was blind with respect to group. The von
Frey filaments (ranging from 0.4 g to 15 g) (North Coast Medical, CA,
USA) were used to apply mechanical stimuli to the hind paw. Each von
Frey hair was held about 1–2 s, with a 10-min interval between each
application. A trial began with the application of the 2 g von Frey
hair. The positive response was defined as a withdrawal of hind paw
upon the stimulus. Whenever a positive response to a stimulus
occurred, the next lower von Frey hair was applied, and whenever a
negative response occurred, the next higher hair was applied. The
testing consisted of five more stimuli after the first change in
response occurred, and the pattern of response was converted to a 50%
von Frey threshold using the method described by Dixon.[24] The test was taken at 1 day before modeling and 1, 3, 5, 7, 9,
11, 13, 15, 17, 19, and 21 days after modeling.
Behavioral assays for ambulatory pain
Rats were placed in a large plastic observation box with smooth floor.
According to the extent of limb use during spontaneous ambulation,
scores were given as follows: (0) normal use, (1) slight limp, (2)
extent between (1) and (3), (3) severe limp, and (4) complete lack of
limb use. Testing was blind with respect to group. The test was taken
at 1 day before modeling and 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21
days after modeling.
Radiology
Rats were anesthetized with sodium pentobarbital and exposed to an X-ray
source (RayNova Pet DR). Roentgenography of the tibia was performed on
postoperative day 21. Radiographs were taken from hind limbs of the
rats and then analyzed by NIH ImageJ (ImageJ, 1.47 v).
Bone and spinal cord histology
On day 21 following inoculation of Walker 256 cells, rats were deeply
anesthetized with sodium pentobarbital (50 mg/kg, intraperitoneal
injection). After transcardial perfused with 0.9% saline followed with
4% paraformaldehyde. Spinal cord (L4-6) were isolated from animals and
fixed in 4% paraformaldehyde at 4°C for 24 h and then transferred to
30% sucrose buffer until the tissues drop to the bottom of the
container. Then the spinal cords were embedded in paraffin and
sections were cut into 8 μm (Leica RM 2165). The other unfixed spinal
cords were stored at −80°C. The tibial bones were preserved in 4%
paraformaldehyde.
Western blot
The spinal cord was homogenized in ice-cold radioimmunoprecipitation
assay (RIPA) buffer containing a cocktail of protease inhibitors
(Sigma). After centrifugation at 12,000 g for 15 min, supernatant was
used for Western blot analysis. Protein concentrations were determined
by BCA method. Equal amounts of protein samples were separated in 10%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Proteins
were transferred onto a polyvinylidene difluoride membrane and then
incubated with the appropriate primary antibodies at 4°C overnight.
The following antibodies were used in this study (ProteinTech): rabbit
anti-GFAP (1:1000, 16825–1-AP), rabbit anti-Iba1 (1:1000, 10904–1-AP),
and mouse anti-GAPDH (1:5000, 60004–1-Ig). Horseradish
peroxidase-conjugated secondary antibodies (1:5000, Thermo Fisher
Scientific, 31460/31430) were used to visualize the primary
antibodies. Imaging System (Bio-Rad, CA, USA) was applied to detect
immunoreactive bands.
Immunofluorescence
Frozen spinal sections (8 μm) were fixed with cold acetone for 10 min and
rinse with PBS for three times. The sections were then blocked with
10% normal donkey serum for 1 h at room temperature. Subsequently, the
sections were incubated with primary antibody, rabbit anti-GFAP
(1:100, 16825–1-AP) or rabbit anti-Iba1 (1:50, 10904–1-AP), overnight
at 4°C. After incubation and being washed with PBS, sections were
incubated with goat anti-mouse IgG H&L (FITC) (1:200, Abcam,
ab6785) at room temperature for 1 h and then examined with a
fluorescence microscope.
Real-time PCR
Total RNA was extracted using TRIzol reagent (Invitrogen) and used to
generate cDNA by EasyScript One-Step gDNA Removal and cDNA Synthesis
SuperMix (TransGen Biotech) with an oligo-dT primer. Real-time
polymerase chain reaction (PCR) was performed using SYBR Select Master
Mix (Life Technology) as recommended by the manufacturer. GAPDH was
used as the internal control. All primers are designed by Thermo
Fisher (Beijing) and listed below:TNF-α-F: 5′-CAAGAGCCCTTGCCCTAAGG-3′TNF-α-R: 5′-CGGACTCCGTGATGTCTAAGTACTT-3′IL-1β-F: 5′-TCAGGAAGGCAGTGTCACTCA-3′IL-1β-R: 5′-CATCATCCCACGAGTCACAGA-3′IL-6-F: 5′-CTGATTGTATGAACAGCGATGATG-3′IL-6-R: 5′-GGTAGAAACGGAACTCCAGAAGAC-3′rGAPDH-F: 5′-GCATCTTCTTGTGCAGTGCC-3′rGAPDH-R: 5′-TACGGCCAAATCCGTTCACA-3′
CCK8 assay
Walker 256 cells (1 × 103) were plated onto 96-well flat
bottom plates in a final volume of 100 μl/well. After attached, cells
were exposed to scorpion at the concentration of 0 mg/ml, 0.5 mg/ml,
2 mg/ml, and 8 mg/ml for 24 h and 48 h. At the end of the above stated
exposure periods, CCK-8 was placed in each of the wells containing the
control samples as well as those containing scorpion exposed samples.
The samples were kept in an incubator for 60 min, after which the
absorbance was measured with MultiskanGo Spectrophotometer (USA) at
450 nm optical density. Suppression of cell proliferation was
determined by the following mathematical relation: [(Mean absorbance
of control – Mean absorbance of exposed)/Mean absorbance of
control) × 100].
Statistical analysis
Each in vivo and in vitro experiment was performed in triplicate and
repeated at least three times. Data analysis was achieved with SPSS
software (version 19.0). Differences between variables were assessed
by one-way analysis of variance, where appropriate. Data are shown as
mean ± standard error of the mean (SEM). p < 0.05 is considered
statistically significant.
Results
Scorpion alleviates BCP behavior
To assess the chronic cancer pain induced by cancer cell injection, pain
behavioral change was evaluated by mechanical allodynia. Rats injected
with Walker 256 carcinoma cells into the tibia and scorpion was given
to rats by gavage according to either prophylactic or reversal
paradigms (Figure
1(a)). No signs of pain behavior up to day 5
postinjection, at which point significant development of mechanical
allodynia and ambulatory pain started to be seen (Figure 1(b)). Prophylactic
treatment was started on day 4 postinjection, since no significant
differences in pain behavior between cancer cell-injected or sham rats
were detected on day 3. Cancer cell-injected rats showed decreased 50%
paw withdraw threshold and increased score of ambulatory pain.
Prophylactic treatment with scorpion in cancer cell-injected rats
significantly attenuated the development of mechanical allodynia from
day 7 to day 21 (Figure 1(b)) and ambulatory pain from day 15 to day 21
(Figure
1(c)). Moreover, to assess the efficacy of scorpion in a
way better resembling the clinical setting, scorpion was administered
on day 14 in reversal treatment group of carcinoma cell-injected rats.
Following the first administration of scorpion, mechanical allodynia
was significantly reduced compared with carcinoma cell-injected rats
from day 15 to day 21 (Figure 1(b)) and the
developed ambulatory pain was significantly reversed from day 15 to
day 21 (Figure
1(c)). All behavioral assessments were undertaken by an
observer blinded to the treatment given. These findings indicated that
scorpion reversed the effect of BCP behavior in both prophylactic and
reversal treatment.
Figure 1.
Scorpion alleviates bone cancer pain behavior.Experimental
paradigm (a); 50% paw withdrawal threshold (b) to von Frey
filaments and score of ambulatory pain (c) in sham and BCP
rats with or without scorpion treatment (prophylactic or
reversal). All data were expressed as the mean ± SEM
(n = 10). BCP versus sham rats (*), prophylactic versus
BCP (#), reversal versus BCP (+) at each corresponding
time point, #/+p < 0.05, ##/++p < 0.01,
***p < 0.001 (Student’s t test).
Scorpion alleviates bone cancer pain behavior.Experimental
paradigm (a); 50% paw withdrawal threshold (b) to von Frey
filaments and score of ambulatory pain (c) in sham and BCPrats with or without scorpion treatment (prophylactic or
reversal). All data were expressed as the mean ± SEM
(n = 10). BCP versus sham rats (*), prophylactic versus
BCP (#), reversal versus BCP (+) at each corresponding
time point, #/+p < 0.05, ##/++p < 0.01,
***p < 0.001 (Student’s t test).
Scorpion attenuates bone destruction
To examine the effect of scorpion on bone destruction, X-ray radiographic
images of tibia were taken at the end point of the study to monitor
the destruction caused by Walker 256 carcinoma cells. The data showed
that no radiological change was found in sham rats (Figure 2(a)).
However, the tibia bone showed radiolucent lesion in the proximal
epiphysis of cancer cell-injected rats, close to the injection site,
and not present in the femur (Figure 2(a)). Prophylactic or
reversal treatments of scorpion significantly attenuated the degree of
tibia destruction in carcinoma cell-injected rats (Figure 2(a)).
Furthermore, representative images of cancer cell-injected tibia
displayed similar results. Cancer cell-injected tibia bearing severe
tumor burden and bone destruction than those of sham group, and tibia
of both prophylactic and reversal treatment of scorpion showed minor
bone destruction than cancer cell-injected group (Figure 2(b)). These findings
indicated that the analgesic effect of scorpion in BCP might through
decreasing the bone destruction caused by cancer cells.
Figure 2.
Scorpion attenuates bone destruction. Representative
radiographs of the tibia bone (a) in sham and BCP rats
with or without scorpion treatment (prophylactic or
reversal). All data were expressed as the mean ± SEM
(n = 10), **p < 0.01, ***p < 0.001 (Student’s
t test). Representative tibia bone
images (b) of sham and BCP rats with or without scorpion
treatment (prophylactic or reversal).
Scorpion attenuates bone destruction. Representative
radiographs of the tibia bone (a) in sham and BCPrats
with or without scorpion treatment (prophylactic or
reversal). All data were expressed as the mean ± SEM
(n = 10), **p < 0.01, ***p < 0.001 (Student’s
t test). Representative tibia bone
images (b) of sham and BCPrats with or without scorpion
treatment (prophylactic or reversal).
Scorpion inhibits the activation of spinal cord astrocytes and
microglia in BCP rats
Previous study showed that spinal cord astrocytes and microglia were
involved in the process of pain. Therefore, we examined the activation
of spinal cord astrocytes and microglia. The expression of glial
fibrillary acidic protein (GFAP), astrocytic biomarker, and ionized
calcium binding adapter molecule 1 (Iba1), microglia biomarker, was
markedly increased in BCPrats, compared with sham group (Figure 3(a)).
This result indicated the activation of spinal cord astrocytes and
microglia induced by bone cancer. Interestingly, the level of GFAP and
Iba1 was significantly decreased in scorpion treated rats, both
prophylactic and reversal treatment (Figure 3(a)). Subsequently,
the expression of GFAP and Iba1 was analyzed by immunofluorescence.
Consistent with previous finding, the expression of GFAP and Iba1 was
upregulated in BCPrats, and scorpion reversed level of GFAP and Iba1
(Figure
3(b)). These data suggested that scorpion inhibited the
activation of astrocytes and microglia.
Figure 3.
Scorpion inhibits the activation of spinal cord astrocytes
and microglia in BCP rats. Levels of GFAP and Iba1 protein
were determined by Western blot (a) and immunofluorescence
(b) (n = 3); scale bar, 100 μm. All data were expressed as
the mean ± SEM (n = 3), ***p < 0.001 (Student’s
t test).
Scorpion inhibits the activation of spinal cord astrocytes
and microglia in BCPrats. Levels of GFAP and Iba1 protein
were determined by Western blot (a) and immunofluorescence
(b) (n = 3); scale bar, 100 μm. All data were expressed as
the mean ± SEM (n = 3), ***p < 0.001 (Student’s
t test).
BCP is a unique condition with features of inflammation.[25] Thus, we tested the expression of inflammatory cytokines in
mRNA level. As expected, TNF-α, IL-6, and IL-1β mRNA level was
upregulated in BCPrats, and scorpion treatment significantly reversed
TNF-α, IL-6, and IL-1β levels (Figure 4(a)–(c)). These
findings indicated that scorpion might inhibit BCP via suppressing
inflammatory cytokines expression.
Figure 4.
Scorpion suppresses inflammatory cytokines expression. Levels
of TNF-α (a), IL-6 (b) and IL-1β (c) mRNA in spinal cord
of bone cancer pain rats were determined by qPCR (n = 3).
All data were expressed as the mean ± SEM (n = 3),
**p < 0.01, ***p < 0.001 (Student’s
t test).
Scorpion suppresses inflammatory cytokines expression. Levels
of TNF-α (a), IL-6 (b) and IL-1β (c) mRNA in spinal cord
of bone cancer painrats were determined by qPCR (n = 3).
All data were expressed as the mean ± SEM (n = 3),
**p < 0.01, ***p < 0.001 (Student’s
t test).
Scorpion represses tumor cell growth
To explore whether scorpion had an effect on tumor cell growth, we tested
the cell viability of Walker 256 cell after scorpion treatment for 24
and 48 h. The results indicated that scorpion significantly suppressed
Walker 256 cell viability compared with control condition (Figure 5(a)),
suggesting that scorpion led to both dose-dependent and time-dependent
decrease in Walker 256 cell viability.
Figure 5.
Scorpion represses tumor cell growth. (a) Walker 256 cells
were treated with the indicated concentration of scorpion
for the indicated times, and cell viability was measured
using the CCK8 method (n = 3). All data were expressed as
the mean ± SEM (n = 3), *p < 0.05, **p < 0.01,
***p < 0.001 (Student’s t test).
Scorpion represses tumor cell growth. (a) Walker 256 cells
were treated with the indicated concentration of scorpion
for the indicated times, and cell viability was measured
using the CCK8 method (n = 3). All data were expressed as
the mean ± SEM (n = 3), *p < 0.05, **p < 0.01,
***p < 0.001 (Student’s t test).
Discussion
The most common types of cancer, including breast, prostate, and lung cancer,
tend to metastasize to the bones. As bone remodeling progresses, severe
spontaneous pain often occurs, which the occurrence and severity of such
pain may be acute and unpredictable.[4] And BCP is considered to be one of the most difficult chronic pains
to fully control, which seriously affects the quality of life in patients.[26] Generally, the treatment of pain from bone metastases involves the
use of multiple complementary approaches including radiotherapy, surgery,
chemotherapy, bisphosphonates, calcitonin, and analgesics.[4,27]
However, BCP is a chronic pain that is very difficult to fully control since
metastasis is usually not limited to a single site.[27] Moreover, the efficacy of commonly used analgesics, such as NSAIDs
and opioids is limited, because of their significant adverse side effects in
the treatment of cancer pain.[27-29] Therefore, we
still need to further seek new analgesics and treatment options. The
injection of Walker 256 ratbreast cancer cells can successfully prepare a
ratBCP model similar to humanBCP.[30,31] The paw withdrawal
thresholds in response to mechanical stimulation and the spontaneous
ambulatory pain score in rats have significantly decreased or increased from
day 3 after the injection of Walker 256 cells into the upper tibia,
suggesting that the BCP model was established successfully.In this study, the effects of nociception on BCP models were investigated by
intragastric administration of scorpion. Scorpion not only effectively
ameliorated mechanical allodynia and pain behavior but also significantly
improved the bone destruction of tibias induced by tumor growth. Moreover,
scorpion inhibited proliferation of Walker 256 cells in a dose- and
time-dependent manner. Our data suggested that intragastric administration
with scorpion could be a potential therapeutic approach for BCP
treatment.The mechanism of BCP includes inflammatory pain and neuropathic pain
components, but it is not a simple addition of these two types of pain. The
BCP includes not only the tumor itself but also the inflammatory reaction,
peripheral sensitization and central sensitization.[32] Role of astrocytes and microglia during pain pathogenesis has been
implicated in several studies.[33-37] Inflammatory
activation of astrocytes and microglia leaded to proinflammatory cytokines
expression and neuronal damage. During BCP, inflammatory signal pathway was
activated and a lot of inflammatory mediators were released.[17,38] In
our study, we found that BCP increased expression of astrocytes and
microglia markers (GFAP and Iba1) in spinal cord, and scorpion treatment
decreased GFAP and Iba1 expression. Meanwhile, the concentration of TNF-α,
IL-6, and IL-1β increased in spinal cord of BCPrats, and scorpion reversed
these inflammatory mediators’ levels. Accordingly, scorpion could be a
possible candidate for BCP treatment.
Conclusion
In the present study, we demonstrated that intragastric administration of
scorpion alleviates BCP through inhibition of bone destruction and glia
activation. Our study provided a safety new approach of BCP treatment.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.
Funding
The author(s) disclosed receipt of the following financial support for the
research, authorship, and/or publication of this article: This study was
supported by National Natural Science Foundation of China (no. 81273923 to
QPW) and Basic Research Project of Key Laboratory of Education Department of
Liaoning Province (no. LZ2016002 to QPW).
Authors: Shao Xia Lin; Lucia Lisi; Cinzia Dello Russo; Paul E Polak; Anthony Sharp; Guy Weinberg; Sergey Kalinin; Douglas L Feinstein Journal: ASN Neuro Date: 2011-04-07 Impact factor: 4.146